Nursing and Health Professions
Lower Respiratory Tract Infection
100%
Child
71%
Patient
57%
Respiratory Syncytial Virus Infection
57%
Malignant Neoplasm
42%
Ribavirin
42%
Mortality
42%
Odds Ratio
28%
Antiviral Therapy
28%
Infection
14%
Corticosteroid
14%
Transplantation
14%
Mortality Rate
14%
Vulnerable Population
14%
Upper Respiratory Tract Infection
14%
Hematologic Malignancy
14%
Male
14%
Immunomodulating Agent
14%
Lymphocytopenia
14%
Pharmacology, Toxicology and Pharmaceutical Science
Lower Respiratory Tract Infection
100%
Respiratory Syncytial Virus Infection
57%
Malignant Neoplasm
42%
Ribavirin
42%
Mortality
42%
Human Respiratory Syncytial Virus
28%
Palivizumab
28%
Corticosteroid
14%
Infection
14%
Mortality Rate
14%
Retrospective Study
14%
Hematologic Malignancy
14%
Cytotoxic Chemotherapy
14%
Lymphocytopenia
14%
Upper Respiratory Tract Infection
14%
Immunomodulating Agent
14%
Immunology and Microbiology
Lower Respiratory Tract
100%
Respiratory Syncytial Virus Infection
57%
Ribavirin
42%
Mortality
42%
Human Respiratory Syncytial Virus
28%
Palivizumab
28%
Mortality Rate
14%
Upper Respiratory Tract
14%
Lymphocytopenia
14%
Vulnerable Population
14%
Immunomodulating Drugs
14%
Age
14%
Hematopoietic Stem Cell Transplantation
14%